one-day-workflow-scheme-for-bacterial-pathogen-detection

One-day Workflow Scheme for Bacterial Pathogen Detection and Antimicrobial Resistance Testing from Blood Cultures

Bloodstream infections are associated with high mortality rates because of the probable manifestation of sepsis, severe sepsis and septic shock1. ...

Erasmus Medical Center

&#x8FD9;&#x9879;&#x7814;&#x7A76;&#x7684;&#x76EE;&#x6807;&#x662F;&#x8BC4;&#x4F30;&#x671F;&#x95F4;&#x4E3B;&#x8981;&#x827E;&#x6ECB;&#x75C5;&#x6BD2;&#x611F;&#x67D3; (PHI) &#x7684;&#x4E34;&#x65F6;&#x7EC4;&#x5408;&#x6297;&#x9006;&#x8F6C;&#x5F55;&#x75C5;&#x6BD2;&#x7597;&#x6CD5; &#xFF08;&#x8F66;&#xFF09; &#x7684;&#x597D;&#x5904;&#x3002;

&#x6CA1;&#x6709;&#x4E0E; 24 &#x6216; 60 &#x5468;&#x7684;&#x6297;&#x9006;&#x8F6C;&#x5F55;&#x75C5;&#x6BD2;&#x6CBB;&#x7597;&#x671F;&#x95F4;&#x4E3B;&#x8981;&#x7684;&#x827E;&#x6ECB;&#x75C5;&#x6BD2;&#x611F;&#x67D3;&#x7684;&#x6CBB;&#x7597;&#xFF1A; &#x968F;&#x673A;&#x51FB; Primo &#x7B80;&#x8C10;&#x632F;&#x52A8;&#x8BD5;&#x9A8C;&#x3002;

The objective of this study was to assess the benefit of temporary combination antiretroviral therapy (cART) during primary HIV infection (PHI).

No treatment versus 24 or 60 weeks of antiretroviral treatment during primary HIV infection: the randomized Primo-SHM trial.

L&#39;objectif de cette &eacute;tude &eacute;tait d&#39;&eacute;valuer le b&eacute;n&eacute;fice d&#39;une th&eacute;rapie antir&eacute;trovirale combinaison temporaire (panier) au cours de la primo-infection VIH (PHI).

Aucun traitement contre 24 ou 60 semaines d&#39;un traitement antir&eacute;troviral au cours de la primo-infection VIH : l&#39;essai randomis&eacute; de Primo-SHM.

Das Ziel dieser Studie war, den Vorteil der tempor&auml;ren antiretrovirale Kombinationstherapie (Einkaufswagen) w&auml;hrend der prim&auml;ren HIV-Infektion (PHI).

Keine Behandlung im Vergleich zu 24 oder 60 Wochen antiretrovirale Behandlung w&auml;hrend der prim&auml;ren HIV-Infektion: Die randomisierte Primo-SHM-Studie.

L&#39;obiettivo di questo studio era di valutare i benefici della terapia antiretrovirale di combinazione temporanea (carrello) durante l&#39;infezione primaria da HIV (PHI).

Nessun trattamento versus 24 o 60 settimane di trattamento antiretrovirale durante l&#39;infezione primaria da HIV: randomized trial di Primo-SHM.

&#x672C;&#x7814;&#x7A76;&#x306E;&#x76EE;&#x7684;&#x306F;&#x3001;&#x30D7;&#x30E9;&#x30A4;&#x30DE;&#x30EA;&#x306E; HIV &#x611F;&#x67D3;&#x75C7; (&#x30D5;&#x30A1;&#x30A4;) &#x4E2D;&#x306B;&#x4E00;&#x6642;&#x4F75;&#x7528;&#x6297;&#x30EC;&#x30C8;&#x30ED; &#x30A6;&#x30A4;&#x30EB;&#x30B9;&#x7642;&#x6CD5; &#xFF08;&#x30AB;&#x30FC;&#x30C8;&#xFF09; &#x306E;&#x5229;&#x70B9;&#x3092;&#x8A55;&#x4FA1;&#x3059;&#x308B;&#x305F;&#x3081;&#x306B;&#x3060;&#x3063;&#x305F;&#x3002;

&#x306A;&#x3044;&#x6CBB;&#x7642;&#x6297;&#x30EC;&#x30C8;&#x30ED; &#x30A6;&#x30A4;&#x30EB;&#x30B9;&#x6CBB;&#x7642; HIV &#x611F;&#x67D3;&#x306E; 24 &#x307E;&#x305F;&#x306F; 60 &#x9031;&#x9593;&#x5BFE;&#xFF1A; &#x30D7;&#x30EA;&#x30E2; SHM &#x306E;&#x7121;&#x4F5C;&#x70BA;&#x5316;&#x8A66;&#x9A13;&#x3002;

&#xC774; &#xC5F0;&#xAD6C;&#xC758; &#xBAA9;&#xC801;&#xC740; &#xAE30;&#xBCF8; HIV &#xAC10;&#xC5FC; (&#xD53C;) &#xD558;&#xB294; &#xB3D9;&#xC548; &#xC784;&#xC2DC; &#xC870;&#xD569; &#xD56D; &#xB808;&#xD2B8;&#xB85C; &#xBC14;&#xC774;&#xB7EC;&#xC2A4; &#xCE58;&#xB8CC; (&#xC7A5;&#xBC14;&#xAD6C;&#xB2C8;)&#xC758; &#xD61C;&#xD0DD;&#xC744; &#xD3C9;&#xAC00; &#xD588;&#xB2E4;.

&#xAE30;&#xBCF8; HIV &#xAC10;&#xC5FC; &#xC2DC; &#xD56D; &#xB808;&#xD2B8;&#xB85C; &#xBC14;&#xC774;&#xB7EC;&#xC2A4; &#xCE58;&#xB8CC;&#xC758; 24 ~ 60 &#xC8FC;&#xC5D0; &#xB300; &#xD55C; &#xCE58;&#xB8CC;: &#xBB34;&#xC791;&#xC704;&#xB85C; &#xD504;&#xB9AC;&#xBAA8; SHM &#xC7AC;&#xD310;.

El objetivo de este estudio fue evaluar el beneficio del tratamiento antirretrov&iacute;rico de combinaci&oacute;n temporal (carro) durante la infecci&oacute;n primaria del VIH (PHI).

Ning&uacute;n tratamiento versus 60 o 24 semanas de tratamiento antirretroviral durante la infecci&oacute;n primaria del VIH: el ensayo aleatorizado de Primo-SHM.

Article	Year
Infection and immunity\| PubMed ID: 11748176	2002
The Journal of infectious diseases\| PubMed ID: 11920324	2002
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America\| PubMed ID: 12060869	2002
Scandinavian journal of infectious diseases\| PubMed ID: 12069031	2002
The Journal of infectious diseases\| PubMed ID: 12195388	2002
Emerging infectious diseases\| PubMed ID: 12498662	2002
The Journal of infectious diseases\| PubMed ID: 12508146	2003
Journal of clinical immunology\| PubMed ID: 12757265	2003
The Journal of experimental medicine\| PubMed ID: 14623910	2003
European cytokine network\| PubMed ID: 14656690	2003
American journal of respiratory and critical care medicine\| PubMed ID: 15447943	2004
Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 15699327	2005
International immunology\| PubMed ID: 16141243	2005
Journal of acquired immune deficiency syndromes (1999)\| PubMed ID: 17195761	2007
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America\| PubMed ID: 17806056	2007
Intensive care medicine\| PubMed ID: 19343323	2009
AIDS (London, England)\| PubMed ID: 19531930	2009
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology\| PubMed ID: 20060779	2010
Intensive care medicine\| PubMed ID: 20721536	2011
Drugs\| PubMed ID: 21568363	2011
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America\| PubMed ID: 21628488	2011
BMC microbiology\| PubMed ID: 21718482	2011
Archives of internal medicine\| PubMed ID: 21788542	2011
Current opinion in critical care\| PubMed ID: 21900768	2011
PloS one\| PubMed ID: 22194790	2011
PloS one\| PubMed ID: 22272297	2012
No treatment versus 24 or 60 weeks of antiretroviral treatment during primary HIV infection: the randomized Primo-SHM trial. PLoS medicine\| PubMed ID: 22479156	2012
British journal of clinical pharmacology\| PubMed ID: 22616681	2012
Clinical immunology (Orlando, Fla.)\| PubMed ID: 22695533	2012

Annelies Verbon

Biography

JoVE Journal Publications

Other Publications